Kmt2a-rearranged Acute Lymphoblastic Leukemia
📧 Sign up to get email alerts when something new happens for Kmt2a-rearranged Acute Lymphoblastic Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-22Clinical Trial Update: A Phase IB Trial of Subcutaneous Blinatumomab in Combination With Revumenib for Patients With KMT2A-rearranged Acute Lymphoblastic Leukemia [Phase 1]
Phase Ib trial evaluating subcutaneous blinatumomab in combination with revumenib for KMT2A-rearranged acute lymphoblastic leukemia; the stu…